Hematology & Oncology Archives - Page 2 of 3

Hematology & Oncology

General

This Blood Test Could Spot More Diseases Than Previously Thought

BlackDoctor Pro Editors

12/17/2024

This Blood Test Could Spot More Diseases Than Previously Thought

CBC tests may predict diverse diseases, enhancing precision medicine. Explore implications for early-stage disease detection in diverse populations.

Hematology & Oncology

How Socioeconomic Factors Affect Sickle Cell in Preschoolers

BlackDoctor Pro Editors

10/09/2024

How Socioeconomic Factors Affect Sickle Cell in Preschoolers

Socioeconomic factors heighten sickle cell complications in preschoolers. Addressing SDOH is crucial for equitable care. Explore implications further.

Hematology & Oncology

CDC Warns of Shortage of Bottles Needed for Crucial Blood Tests

BlackDoctor Pro Editors

07/25/2024

CDC Warns of Shortage of Bottles Needed for Crucial Blood Tests

CDC warns blood culture bottle shortage may lead to misdiagnoses, impacting antibiotic use in Black, underserved populations. Read more.

Hematology & Oncology

New Management of Sickle Cell Disease in Children and Teens

BlackDoctor Pro Editors

07/23/2024

New Management of Sickle Cell Disease in Children and Teens

Comprehensive SCD care in children requires a multidisciplinary approach, addressing racial disparities and enhancing quality of life. Explore detailed strategies.

Hematology & Oncology

doctor talking to beta thalassemia patient

BlackDoctor Pro Editors

01/17/2024

FDA Clears Sickle Cell Drug to Treat Beta-Thalassemia

FDA approves Casgevy for beta-thalassemia, expanding treatment options for underserved communities. Explore implications for managing sickle cell and beta-thalassemia.

Hematology & Oncology

ashantai hathaway

09/12/2023

Racial Discrimination Linked to CRP Increase in Black Women with Lupus

Racial discrimination increases CRP in Black women with lupus, impacting health outcomes. Explore policy changes for health equity.

Hematology & Oncology

ashantai hathaway

09/12/2023

Watch: Hematologist Explains Why Myeloma Is Twice as Deadly for African Americans

Myeloma is twice as deadly for Blacks. Why? Watch Dr. Cole discuss racial disparities and implications for treatment.

Hematology & Oncology

Camille McClellan

03/18/2023

223, Black Women More Likely to Have Idiopathic Intracranial HTN

IIH disproportionately affects Black and Hispanic women in low-income areas. Read full analysis for implications on practice.

General

BlackDoctor Pro Editors

02/23/2023

QI Program Less Likely Disparities in BP Control Between Black, White Patients, 18-49 years

QI program reduces but doesn't eliminate BP control disparities between Black, White patients. Targeted interventions needed. Explore future strategies.

General

BlackDoctor Pro Editors

02/16/2023

U.S. 28.8% Maternal Mortality, Morbidity Increased in Sickle Cell Disease

Sickle cell disease elevates maternal mortality, morbidity, with racial disparities explaining 28.9% increased risk. Read the full analysis.

Hematology & Oncology

Maya Moore

11/29/2022

FDA Approves First Gene Therapy for Adults With Hemophilia B

FDA approves Hemgenix, first gene therapy for adult hemophilia B, reducing bleeding rates significantly. Explore implications for patient care.

AI-Powered Search. Human-Created Content.

What is the most crucial step to reduce Black maternal mortality rates?

Improve healthcare access

Increase racial equity

Enhance prenatal care

Raise COVID-19 awareness

Expert Medical Insights, Straight to Your Inbox

Insights That Keep Black Healthcare Leaders at the Forefront

By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.

Empowering Culturally-Sensitive Healthcare Professionals

BlackDoctor Pro is an online destination created specifically for Black doctors and culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies. We are committed to empowering HCPs with the knowledge, resources, and support needed to achieve exceptional health outcomes in black communities.